This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BONE_CARTILAGE_LIMBS_EXALLC for full statistics.
Malignant neoplasm of bone and articular cartilage of limbs
C3_BONE_CARTILAGE_LIMBS
bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
143 |
4. Check minimum number of eventsNone |
143 |
5. Include endpointsNone |
143 |
6. Filter based on genotype QC (FinnGen only) |
143 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bone and articular cartilage of limbs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bone and articular cartilage
- Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 143 | 58 | 85 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.04 |
| Median age at first event (years) | 32.53 | 31.58 | 33.18 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 134
- Matched controls
- 1340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
206.9
67.2
65
6
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
49.0
44
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
44.2
40
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
33.8
31
*
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
30.4
28
*
130
Kela drug reimbursment
Malignant tumour
16.8
30.4
51
47
NF3AA
NOMESCO Finland
Femur X-ray examination
61.8
29.0
33
7
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
25.9
24
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
24.7
23
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
24.7
23
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
260.8
22.3
22
*
L03AA02
ATC
filgrastim; parenteral
29.1
21.0
28
12
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
20.3
19
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
17.3
18.3
29
21
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
14.6
18.2
31
27
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
8.4
18.1
43
71
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
17.0
16
*
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
68.7
16.2
18
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
43.8
15.9
19
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
27.3
15.7
21
9
N02AA05
ATC
oxycodone; systemic
6.4
15.2
44
95
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
167.5
14.8
15
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
167.5
14.8
15
*
N03AX16
ATC
pregabalin; oral
5.2
14.4
52
145
R4110
NOMESCO Finland
Physiotherapy
4.7
14.2
60
198
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
83.5
13.9
15
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
24.3
13.8
19
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
13.8
84
386
ZXE20
NOMESCO Finland
More than three and less than five hours
5.8
13.6
42
97
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
12.7
12
*
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
41.8
12.5
15
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.5
12.1
20
16
B01AB05
ATC
enoxaparin; parenteral
4.1
12.1
60
223
GD1AD
NOMESCO Finland
Thorax CT examination
12.9
12.0
21
19
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
33.4
11.9
15
5
WX306
NOMESCO Finland
Lumbar epidural anesthesy
9.1
11.8
25
33
TPX15
NOMESCO Finland
Removal of vascular injection port
+∞
11.6
11
*
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
11.6
11
*
ZXA05
NOMESCO Finland
Left side
4.1
11.0
51
176
WW500
NOMESCO Finland
Blood transfusion
12.8
11.0
19
17
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.0
11.0
23
30
A04AA01
ATC
ondansetron; systemic, rectal
7.6
10.7
25
39
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
118.9
10.6
11
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
118.9
10.6
11
*
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.6
10
*
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
10.6
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.2
10.5
29
57
JN4BD
NOMESCO Finland
Extensive body CT
5.3
10.4
33
77
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.2
10.3
23
33
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
10.3
40
116
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
43.6
10.1
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
10.1
59
244
NG1AD
NOMESCO Finland
Knee CT examination
28.5
10.0
13
5
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.0
10.0
46
156
NB6AA
NOMESCO Finland
Humerus X-ray examination
32.7
9.6
12
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
107.3
9.5
10
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
107.3
9.5
10
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
+∞
9.5
9
*
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
9.5
9
*
9101
FHL
Bone biopsy
+∞
9.5
9
*
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
15.2
9.4
15
11
B01AB10
ATC
tinzaparin; parenteral
7.1
9.1
22
36
WF049
NOMESCO Finland
Radiotherapy of metastasis
11.9
9.1
16
15
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.9
8.9
22
37
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
8.8
36
108
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
+∞
8.4
8
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
8.4
8
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
8.4
8
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
8.4
8
*
N02AX02
ATC
tramadol; systemic, rectal
3.0
8.2
67
339
WF004
NOMESCO Finland
Palliative radiotherapy
11.0
7.7
14
14
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.2
7.6
20
37
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.2
7.6
20
37
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
7.0
7.6
18
29
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
84.6
7.5
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
17.0
7.4
11
7
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
7.4
7
*
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
7.4
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
7.4
7
*
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
+∞
7.4
7
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.8
7.1
65
341
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
9.1
7.0
14
17
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
6.6
6.9
17
29
J04AB02
ATC
rifampicin; systemic
17.8
6.9
10
6
NFQ20
NOMESCO Finland
Amputation of femur
23.9
6.8
9
*
ZX120
NOMESCO Finland
Intravenous
4.6
6.7
23
58
ZXE00
NOMESCO Finland
One hour or less
2.6
6.7
66
360
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
15.3
6.5
10
7
L03AA13
ATC
pegfilgrastim; parenteral
8.9
6.5
13
16
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
8.9
6.5
13
16
NGQ20
NOMESCO Finland
Amputation of lower leg
73.2
6.5
7
*
9102
FHL
Trepanation or removal of the local bone process
73.2
6.5
7
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
11.9
6.4
11
10
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.5
6.3
18
37
L28
ICPC
Limited function/disability (L)
3.7
6.3
28
90
NGR40
NOMESCO Finland
Extensive excision of tumor of knee or lower leg with repair
+∞
6.3
6
*
C40.10
ICD-10 Finland
Malignant tumor of the upper limb's short bones without histology
+∞
6.3
6
*
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
+∞
6.3
6
*
Z47.8
ICD-10 Finland
Other specified orthopaedic follow-up care
+∞
6.3
6
*
C40.12
ICD-10 Finland
Chondrosarcoma of the short bones of the upper extremity
+∞
6.3
6
*
C40.23
ICD-10 Finland
Ewing's sarcoma in the long bones of the lower extremity
+∞
6.3
6
*
NGB99
NOMESCO Finland
Other primary prosthetic replacement of knee joint, other or unspecified
+∞
6.3
6
*
NF3AD
NOMESCO Finland
Femur CT
+∞
6.3
6
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
6.3
25
73
Z3226
NOMESCO Finland
Physiotherapist
3.2
6.3
35
134
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.6
6.2
15
25
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.6
6.2
15
25
H02AB02
ATC
dexamethasone; systemic
4.1
6.1
23
64
WX402
NOMESCO Finland
General anaesthesia
3.2
6.1
33
123
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
78
331
3.98
15.12
4.6
2.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
64
254
3.75
13.37
5.3
2.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
90
463
3.55
12.24
14.0
7.9
mmol/l
1.2
1.2
0.02
79
424
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
12
11.82
12.13
1.2
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
85
441
3.29
11.04
10.8
4.9
g/l
35.2
36.1
0.95
79
422
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
93
510
3.36
10.97
16.7
8.6
mmol/l
1.2
1.2
0.07
76
443
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
23
7.71
10.81
1.4
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
370
3.07
9.97
9.9
3.1
mmol/l
2.3
2.4
0.42
68
323
(3042936) Bacteria identified in Isolate by Culture
42
152
3.50
9.71
2.5
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
23
7.17
9.55
1.8
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
88
499
2.99
9.22
6.4
4.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
80
435
2.90
9.00
3.0
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
61
293
2.89
8.56
6.5
4.2
ph
7.4
7.4
0.05
13
53
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
28
5.87
7.91
1.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
21
6.71
7.86
1.4
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
69
369
2.68
7.70
10.5
6.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
30
5.47
7.36
1.5
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
13
8.20
7.21
1.4
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
60
311
2.60
6.99
8.1
4.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
17
6.93
6.88
1.3
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
115
3.16
6.72
2.3
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
99
663
2.60
6.54
26.0
9.7
e9/l
3.5
4.1
2.37
90
583
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
117
3.11
6.52
2.4
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
88
561
2.48
6.42
10.2
6.3
e9/l
0.5
0.6
1.12
81
491
(3006315) Basophils [#/volume] in Blood
88
561
2.48
6.42
10.3
6.3
e9/l
0.0
0.0
1.69
81
491
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
30
5.06
6.36
16.2
2.6
u/ml
0.3
0.4
—
9
14
(3003396) Base excess in Arterial blood by calculation
31
119
3.05
6.32
12.5
12.1
mmol/l
0.8
0.7
0.13
26
103
(3013115) Eosinophils [#/volume] in Blood
89
575
2.45
6.23
11.8
6.8
e9/l
0.2
0.2
1.70
83
511
(3019198) Lymphocytes [#/volume] in Blood
89
576
2.44
6.20
10.2
6.4
e9/l
1.6
1.8
2.60
82
514
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
8
13.31
6.18
1.4
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
73
437
2.37
6.01
12.8
8.3
inr
1.1
1.2
0.52
17
129
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
38
173
2.63
5.62
2.4
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
34
4.46
5.50
2.8
2.1
—
—
—
0
0
(4035726)
25
94
3.01
5.25
2.0
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
53
293
2.29
5.08
26.8
6.9
—
—
—
0
0
(3002256) Pathology report gross observation
31
136
2.63
4.89
1.5
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
8
10.50
4.58
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
109
830
2.32
4.45
5.6
4.1
mm/h
14.0
11.0
1.23
103
761
(3004588) Protein electrophoresis panel - Serum or Plasma
19
67
3.12
4.42
3.2
2.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
22
4.81
4.37
7.3
4.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
51
3.41
4.36
13.9
20.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
98
2.74
4.33
4.7
3.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
118
2.59
4.27
2.4
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
75
2.94
4.20
30.7
8.3
mmol/l
24.3
24.4
0.05
20
75
(44790047)
9
14
6.78
4.05
1.7
1.4
—
—
—
0
0
(44790049)
9
14
6.78
4.05
1.7
1.4
—
—
—
0
0
(44806118)
9
14
6.78
4.05
1.7
1.4
—
—
—
0
0
(44790048)
9
14
6.78
4.05
1.7
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
99
743
2.08
3.95
5.0
4.3
—
—
—
0
0
(3044889) 12 lead EKG panel
97
723
2.06
3.94
4.6
3.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
62
398
1.98
3.83
4.7
3.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
12
6.99
3.72
1.1
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
93
2.61
3.70
1.3
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
9
8.10
3.60
1.1
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
48
289
1.99
3.51
3.1
3.1
umol/l
7698.2
4690.2
0.15
43
248
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
14
5.98
3.39
1.1
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
72
503
1.87
3.34
19.5
9.3
e9/l
0.0
0.0
0.25
64
412
(3000991) Gas panel - Venous blood
23
105
2.42
3.31
27.4
8.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
23
106
2.39
3.24
2.2
4.5
ug/l
2.2
49.1
0.59
17
84
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
15
5.58
3.24
1.1
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
19
80
2.59
3.22
3.8
4.1
ng/l
87.7
76.7
0.19
19
72
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
36
201
2.06
3.21
4.0
3.8
ng/l
41.4
124.5
1.39
31
160
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
29
3.63
3.11
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
16
5.23
3.10
2.3
4.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
48
304
1.87
2.96
3.5
2.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
20
91
2.39
2.90
4.3
4.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
92
713
1.81
2.88
5.1
4.4
—
376.8
—
0
13
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
10
6.20
2.72
2.5
2.1
pg
30.3
33.3
—
6
10
(3030467) Casts [#/volume] in Urine by Automated count
49
320
1.81
2.71
3.6
2.8
e6/l
0.3
0.3
0.17
38
240
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
49
320
1.81
2.71
4.4
3.6
ng/l
1404.8
1142.2
0.14
44
268
(3017181) Myelocytes/100 leukocytes in Blood
21
101
2.26
2.69
2.6
4.2
%
1.2
1.1
0.05
15
32
(3002582) Erythrocytes [#/volume] in Urine
52
349
1.77
2.61
4.2
2.9
e6/l
52.9
226.9
0.46
41
272
(3002179) Metamyelocytes/100 leukocytes in Blood
19
89
2.31
2.58
2.5
4.2
%
0.6
0.5
0.14
14
21
(3045788) Cell count panel - Pleural fluid
5
7
7.35
2.57
1.2
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
57
2.61
2.54
2.0
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
113
953
1.89
2.46
37.5
16.6
%
14.1
13.6
2.96
113
937
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
22
3.79
2.40
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
22
3.79
2.40
1.6
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
17
4.27
2.39
4.0
2.4
%
60.3
56.5
—
7
17
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
136
2.02
2.36
13.5
7.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
28
3.36
2.35
4.1
3.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
56
394
1.69
2.33
5.2
3.5
e6/l
46.5
86.9
0.40
43
288
(3017354) Segmented neutrophils/100 leukocytes in Blood
6
13
4.77
2.29
1.8
2.8
%
50.2
57.3
—
6
7
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
18
4.03
2.28
1.3
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
120
1043
1.94
2.23
24.6
12.8
ml/min/173m2
89.0
84.4
1.02
107
849
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
156
1.90
2.16
1.5
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
19
97
2.11
2.12
3.4
2.6
g/l
0.2
0.2
1.25
19
92
(3044941) Cell count panel - Synovial fluid
5
10
5.14
2.09
1.8
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
10
5.14
2.09
3.2
2.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
15
4.13
2.06
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
15
4.13
2.06
1.0
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
92
2.09
2.00
2.5
4.4
%
0.0
0.3
1.77
13
27
(3003694) ABO and Rh group [Type] in Blood
45
310
1.66
1.99
1.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
128
1150
2.08
1.96
33.0
14.0
mg/l
27.7
22.8
0.82
116
882
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
16
3.86
1.95
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
51
0.00
1.93
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
17
3.64
1.86
3.7
2.3
e9/l
3.9
3.9
—
6
17
(4146454)
5
12
4.27
1.84
1.4
2.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
12
4.27
1.84
2.6
2.5
—
357.0
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
30
2.76
1.75
3.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
13
3.94
1.73
1.0
3.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
42
2.48
1.72
1.8
3.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.25
1.68
1.2
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.25
1.68
1.2
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
77
2.06
1.66
2.7
2.4
ml/min/173m2
92.8
69.7
—
6
33
(3026008) Bacteria identified in Urine by Culture
43
306
1.58
1.64
3.8
3.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
32
2.59
1.62
1.5
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
132
1218
2.09
1.56
20.9
10.1
u/l
26.1
26.5
0.12
127
1167
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
33
2.51
1.56
1.3
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
30
198
1.65
1.54
1.5
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
15
3.41
1.53
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
28
183
1.66
1.49
3.0
2.3
umol/l
11.8
14.5
0.90
28
168
(3019225) pH of Specimen
18
103
1.86
1.49
10.7
5.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
5
16
3.20
1.45
3.2
2.4
e9/l
1.0
1.5
—
5
5
(3013290) Carbon dioxide [Partial pressure] in Blood
6
22
2.80
1.45
4.2
2.2
kpa
5.1
5.0
—
6
22
(3027315) Oxygen [Partial pressure] in Blood
6
22
2.80
1.45
4.2
2.2
kpa
6.5
8.3
—
6
22
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
16
90
1.88
1.40
8.4
3.6
kpa
5.1
4.9
0.75
16
83
(40761511) CBC panel - Blood by Automated count
131
1214
1.94
1.39
25.3
12.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
23
2.68
1.38
1.7
1.2
—
—
—
0
0
(3012544) pH of Venous blood
19
114
1.77
1.36
22.9
5.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
131
1.71
1.33
1.5
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
24
2.56
1.32
1.7
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
117
1057
1.59
1.31
34.7
14.4
%
37.2
40.7
4.16
86
794
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
15
86
1.83
1.24
8.1
3.7
mmol/l
1.8
1.1
0.50
15
62
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
19
2.69
1.22
1.0
2.9
u/ml
16.8
52.0
—
5
19
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
26
2.36
1.20
1.3
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
55
438
1.42
1.17
2.5
2.4
nmol/l
76.8
76.9
0.00
48
377
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
162
0.53
1.17
2.0
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
36
0.00
1.15
0.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
74
1.83
1.11
5.8
10.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
177
0.53
1.11
1.9
2.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
41
2.01
1.10
12.7
2.9
kpa
9.3
8.7
—
8
36
(3019230) Fractional oxyhemoglobin in Venous blood
5
21
2.43
1.10
4.6
8.3
%
45.7
67.8
—
5
21
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
21
2.43
1.10
1.0
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
45
350
1.42
1.08
3.8
3.2
mmol/l
7.8
7.8
0.03
36
307
(3035350) Ketones [Presence] in Urine by Test strip
64
531
1.37
1.05
4.8
3.6
estimate
0.0
0.0
0.00
15
109
(40761536) Microorganisms panel - Urine sediment
15
91
1.72
1.05
5.5
2.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
76
1.78
1.03
1.8
1.6
—
—
—
0
0
(3020891) Body temperature
9
48
1.93
1.02
14.0
4.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
70
1.78
0.96
9.5
3.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
20
135
1.56
0.95
8.4
3.3
%
2.5
1.7
2.03
20
126
(3004789) Transferrin [Mass/volume] in Serum or Plasma
24
170
1.49
0.93
3.4
2.3
g/l
2.4
2.4
0.24
24
157
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
36
277
1.40
0.91
2.4
2.3
mg/l
2.8
2.9
0.11
30
243
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
51
416
1.35
0.91
5.5
3.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
17
112
1.59
0.90
2.3
2.3
nmol/l
10.7
13.4
0.64
11
103
(40768797) Stomach Pathology biopsy report
20
138
1.52
0.87
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
91
815
1.32
0.83
5.2
3.7
pmol/l
14.8
14.6
0.23
82
732
(3024354) Oxygen [Partial pressure] in Venous blood
15
98
1.59
0.82
22.3
4.8
kpa
4.2
4.7
0.51
15
93
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
51
422
1.32
0.82
5.3
4.1
ng/l
22.4
39.8
1.01
42
297
(3000330) Specific gravity of Urine by Test strip
8
48
1.71
0.80
2.3
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
63
539
1.30
0.79
5.9
4.9
estimate
0.0
0.0
0.00
15
107
(3050129) First trimester maternal screen panel - Serum or Plasma
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(3036489) Thrombin time
9
53
1.74
0.77
10.0
2.2
s
20.8
22.5
—
9
46
(3024928) Oxygen saturation in Venous blood
5
23
2.21
0.77
1.6
9.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
23
2.21
0.77
1.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
23
2.21
0.77
4.2
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
24
2.12
0.75
1.6
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
24
2.12
0.75
1.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
31
241
1.37
0.74
4.1
1.9
mg/l
2.0
1.7
0.19
25
189
(3011397) Hemoglobin [Presence] in Urine by Test strip
30
232
1.37
0.74
4.5
3.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
143
0.60
0.74
1.3
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
56
1.65
0.74
10.0
5.7
%
1.3
1.1
—
9
56
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
26
1.96
0.71
1.4
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
69
1.64
0.70
1.5
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
63
547
1.27
0.69
4.9
3.6
estimate
0.0
0.0
0.00
15
105
(1761482) Bacteria [#/volume] in Urine by Culture
5
27
1.88
0.69
3.6
5.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
174
1.38
0.65
4.0
2.7
e6/l
2.9
1.6
0.42
11
100
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
20
0.00
0.61
0.0
1.7
—
5.1
—
0
14
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
21
0.00
0.60
0.0
1.1
—
8.4
—
0
15
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
35
1.74
0.58
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
386
0.78
0.56
2.8
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
243
1.30
0.56
1.5
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
117
1.41
0.55
4.9
2.0
nmol/l
350.7
372.1
0.21
16
110
(3025941) Bacteria identified in Stool by Culture
9
63
1.46
0.53
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
37
310
1.26
0.53
4.5
3.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
40
1.52
0.52
1.7
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
36
303
1.25
0.50
3.4
3.3
mg/l
2112.6
57.1
0.48
23
201
(3029937) Albumin [Presence] in Urine by Test strip
35
294
1.25
0.49
6.5
4.0
estimate
0.0
0.0
0.00
15
106
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
109
1029
1.25
0.49
5.7
4.3
mu/l
2.2
1.9
0.99
97
927
(3013512) EKG study
37
313
1.25
0.49
5.1
4.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
192
1.30
0.49
2.9
2.6
e6/l
1.8
0.8
0.84
13
118
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
49
429
1.22
0.47
4.2
5.0
ug/l
2.1
2.1
0.06
43
385
(3019832) Treponema pallidum Ab [Presence] in Serum
9
129
0.68
0.45
2.0
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
184
0.73
0.45
1.3
1.3
iu/ml
126.3
27.8
—
6
64
(3020682) Albumin/Creatinine [Ratio] in Urine
37
318
1.22
0.43
3.7
4.0
mg/mmol
4.8
8.4
0.64
22
205
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
35
1.44
0.39
1.2
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
18
145
1.28
0.36
5.0
4.3
%
29.0
30.7
0.24
11
91
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.41
0.35
2.0
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
43
1.41
0.35
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
16
127
1.29
0.35
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
47
422
1.17
0.34
1.8
1.9
pmol/l
98.5
91.1
0.32
23
220
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
46
1.32
0.33
2.0
2.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
46
1.32
0.33
2.0
1.3
—
—
—
0
0
(3015736) pH of Urine
46
414
1.16
0.32
4.2
3.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
55
1.29
0.30
2.0
2.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
73
776
0.88
0.29
3.8
3.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
118
0.75
0.28
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
95
992
0.87
0.28
6.5
5.7
mmol/mol
40.2
40.0
0.05
83
928
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
81
0.73
0.25
1.8
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
40
1.26
0.22
5.6
3.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
41
1.23
0.22
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
6.4
—
0
10
(21494434) Karyotype in Bone marrow
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
5.0
—
98.4
—
0
12
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
2.1
—
0
7
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
421.7
—
0
7
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
44.2
—
0
6
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
301.0
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
106
1088
0.90
0.17
4.9
4.2
mmol/l
1.4
1.4
0.34
93
993
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
102
1048
0.91
0.16
4.4
3.9
mmol/l
1.3
1.3
0.12
88
958
(3027944) Amphetamines [Presence] in Urine
6
76
0.78
0.16
2.2
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
75
0.79
0.16
3.5
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
75
0.79
0.16
2.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
75
0.79
0.16
2.2
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
101
982
1.10
0.16
42.4
17.9
g/l
332.5
333.6
0.57
101
977
(3019150) Specific gravity of Urine by Refractometry
27
248
1.11
0.14
5.3
4.1
kg/l
1.0
1.0
—
5
30
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
107
1093
0.92
0.13
4.8
4.3
mmol/l
4.4
4.6
1.06
95
1002
(3019309) Folate [Moles/volume] in Red Blood Cells
18
197
0.90
0.10
1.6
1.6
nmol/l
1222.3
1209.7
0.02
11
149
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
55
1.09
0.09
1.8
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
64
0.77
0.08
1.8
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
110
1083
1.07
0.08
4.8
4.4
mmol/l
5.8
5.9
0.25
100
985
(3016879) Cocaine [Presence] in Urine
6
71
0.84
0.08
2.2
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
74
0.80
0.08
3.3
2.4
—
—
—
0
0
(4010399)
7
80
0.87
0.07
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
103
0.87
0.06
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
27
258
1.06
0.05
10.0
5.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
271
0.95
0.04
3.4
1.5
g/l
2.1
2.3
0.19
18
161
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
24
250
0.95
0.03
2.2
2.8
ug/l
1.0
0.8
0.44
18
164
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
110
1110
0.96
0.03
4.9
4.7
mmol/l
2.6
2.7
0.55
97
1014
(3000492) Spirometry study
11
106
1.04
0.00
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
336
1.02
0.00
4.1
4.5
%
22.9
21.2
0.24
18
166
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
143
0.98
0.00
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
23
232
0.99
0.00
1.3
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
1.3
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(44813793)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
13.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
92
0.98
0.00
1.2
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.1
—
8.6
—
0
8
(3023420) DNA double strand Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
9.6
—
759.0
—
0
9
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
11.4
—
0
6
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
203.4
—
0
7
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
1207.7
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
54
0.92
0.00
2.4
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
91.0
—
0
5
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
46.8
—
0
5
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
395.3
—
0
6
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
73.8
—
0
6
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
10.2
—
1483.3
—
0
9
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4281824)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
93
0.97
0.00
1.9
1.8
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
101.6
—
0
8
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BONE_CARTILAGE_LIMBS – Malignant neoplasm of bone and articular cartilage of limbs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).